共 88 条
[1]
Amgen Inc.., Apremilast (US prescribing information)
[2]
[Anonymous], [33] European Medicines Agency. Resumo das Caracteristicas do Medicamento (Anexo I). In Mysimba: Cloridrato de Naltrexona+Cloridrato de Bupropiom. 2020 [acedido a 2 de junho de 2022]. Disponivel em: https://www.ema.europa.eu/en/documents/product-information/mysimba-epar-productinformation_pt.pdf
[3]
[Anonymous], Clinical review report: guselkumab (Tremfya)
[4]
[Anonymous], Clinical review report: tildrakizumab (Ilumya)
[5]
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis A Review
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2020, 323 (19)
:1945-1960
[7]
Bausch Health USA LLC.., Brodalumab (US prescribing information)
[9]
Blizniewska-Kowalska K., 2023, J. Affect. Disord. Rep., V14, DOI [DOI 10.1016/J.JADR.2023.100610, 10.1016/j.jadr.2023.100610]
[10]
Canadian Agency for Drugs and Technologies in Health., Bimekizumab (Bimzelz)